{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:41:31Z","timestamp":1790779291799,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci. China Life Sci."],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s11427-024-2691-0","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T07:04:06Z","timestamp":1727679846000},"page":"431-440","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Serum ECM1 is a promising biomarker for staging and monitoring fibrosis in patients with chronic hepatitis B"],"prefix":"10.1007","volume":"68","author":[{"given":"Lian","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shipeng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jichao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyang","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaguang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlin","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqi","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"key":"2691_CR1","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/hep.21496","volume":"45","author":"P Angulo","year":"2007","unstructured":"Angulo, P., Hui, J.M., Marchesini, G., Bugianesi, E., George, J., Farrell, G.C., Enders, F., Saksena, S., Burt, A.D., Bida, J.P., et al. (2007). The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 45, 846\u2013854.","journal-title":"Hepatology"},{"key":"2691_CR2","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.jhep.2022.03.026","volume":"76","author":"QM Anstee","year":"2022","unstructured":"Anstee, Q.M., Castera, L., and Loomba, R. (2022). Impact of non-invasive biomarkers on hepatology practice: past, present and future. J Hepatol 76, 1362\u20131378.","journal-title":"J Hepatol"},{"key":"2691_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller, R., and Brenner, D.A. (2005). Liver fibrosis. J Clin Invest 115, 209\u2013218.","journal-title":"J Clin Invest"},{"key":"2691_CR4","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1056\/NEJM200102153440706","volume":"344","author":"AA Bravo","year":"2001","unstructured":"Bravo, A.A., Sheth, S.G., and Chopra, S. (2001). Liver biopsy. N Engl J Med 344, 495\u2013500.","journal-title":"N Engl J Med"},{"key":"2691_CR5","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.jhep.2015.07.033","volume":"63","author":"J Chang","year":"2015","unstructured":"Chang, J., Lan, T., Li, C., Ji, X., Zheng, L., Gou, H., Ou, Y., Wu, T., Qi, C., Zhang, Q., et al. (2015). Activation of Slit2-Robo1 signaling promotes liver fibrosis. J Hepatol 63, 1413\u20131420.","journal-title":"J Hepatol"},{"key":"2691_CR6","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/apt.12590","volume":"39","author":"DT Chao","year":"2014","unstructured":"Chao, D.T., Lim, J.K., Ayoub, W.S., Nguyen, L.H., and Nguyen, M.H. (2014). Systematic review with meta-analysis: the proportion of chronic hepatitis B patients with normal alanine transaminase \u2a7d40 IU\/L and significant hepatic fibrosis. Aliment Pharmacol Ther 39, 349\u2013358.","journal-title":"Aliment Pharmacol Ther"},{"key":"2691_CR7","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","volume":"79","author":"H Devarbhavi","year":"2023","unstructured":"Devarbhavi, H., Asrani, S.K., Arab, J.P., Nartey, Y.A., Pose, E., and Kamath, P.S. (2023). Global burden of liver disease: 2023 update. J Hepatol 79, 516\u2013537.","journal-title":"J Hepatol"},{"key":"2691_CR8","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.jhep.2011.09.024","volume":"56","author":"EL Ellis","year":"2012","unstructured":"Ellis, E.L., and Mann, D.A. (2012). Clinical evidence for the regression of liver fibrosis. J Hepatol 56, 1171\u20131180.","journal-title":"J Hepatol"},{"key":"2691_CR9","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1016\/j.cgh.2023.03.005","volume":"21","author":"R Fan","year":"2023","unstructured":"Fan, R., Li, G., Yu, N., Chang, X., Arshad, T., Liu, W.Y., Chen, Y., Wong, G.L.H., Jiang, Y., Liang, X., et al. (2023). aMAP score and its combination with liver stiffness measurement accurately assess liver fibrosis in chronic hepatitis B patients. Clin Gastroenterol Hepatol 21, 3070\u20133079.e13.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2691_CR10","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1053\/j.gastro.2019.07.036","volume":"157","author":"W Fan","year":"2019","unstructured":"Fan, W., Liu, T., Chen, W., Hammad, S., Longerich, T., Hausser, I., Fu, Y., Li, N., He, Y., Liu, C., et al. (2019). ECM1 prevents activation of transforming growth factor \u03b2, hepatic stellate cells, and fibrogenesis in mice. Gastroenterology 157, 1352\u20131367.e13.","journal-title":"Gastroenterology"},{"key":"2691_CR11","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1053\/j.gastro.2008.01.034","volume":"134","author":"M Friedrich-Rust","year":"2008","unstructured":"Friedrich-Rust, M., Ong, M.F., Martens, S., Sarrazin, C., Bojunga, J., Zeuzem, S., and Herrmann, E. (2008). Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 134, 960\u2013974.e8.","journal-title":"Gastroenterology"},{"key":"2691_CR12","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1016\/j.cgh.2021.12.034","volume":"20","author":"I Graupera","year":"2022","unstructured":"Graupera, I., Thiele, M., Serra-Burriel, M., Caballeria, L., Roulot, D., Wong, G.L.H., Fabrellas, N., Guha, I.N., Arslanow, A., Exp\u00f3sito, C., et al. (2022). Low accuracy of FIB-4 and NAFLD fibrosis scores for screening for liver fibrosis in the population. Clin Gastroenterol Hepatol 20, 2567\u20132576.e6.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2691_CR13","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.14309\/ajg.0000000000001239","volume":"116","author":"D Ji","year":"2021","unstructured":"Ji, D., Chen, Y., Shang, Q., Liu, H., Tan, L., Wang, J., Chen, Y., Li, Q., Long, Q., Song, L., et al. (2021). Unreliable estimation of fibrosis regression during treatment by liver stiffness measurement in patients with chronic hepatitis B. Am J Gastroenterol 116, 1676\u20131685.","journal-title":"Am J Gastroenterol"},{"key":"2691_CR14","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/j.1478-3231.2009.02192.x","volume":"30","author":"BK Kim","year":"2010","unstructured":"Kim, B.K., Kim, D.Y., Park, J.Y., Ahn, S.H., Chon, C.Y., Kim, J.K., Paik, Y.H., Lee, K.S., Park, Y.N., and Han, K.H. (2010). Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients. Liver Int 30, 546\u2013553.","journal-title":"Liver Int"},{"key":"2691_CR15","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jhep.2023.04.002","volume":"79","author":"M Kjaergaard","year":"2023","unstructured":"Kjaergaard, M., Lindvig, K.P., Thorhauge, K.H., Andersen, P., Hansen, J.K., Kastrup, N., Jensen, J.M., Hansen, C.D., Johansen, S., Israelsen, M., et al. (2023). Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease. J Hepatol 79, 277\u2013286.","journal-title":"J Hepatol"},{"key":"2691_CR16","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1053\/j.gastro.2008.02.075","volume":"134","author":"M Kumar","year":"2008","unstructured":"Kumar, M., Sarin, S.K., Hissar, S., Pande, C., Sakhuja, P., Sharma, B.C., Chauhan, R., and Bose, S. (2008). Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT. Gastroenterology 134, 1376\u20131384.","journal-title":"Gastroenterology"},{"key":"2691_CR17","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jhep.2014.02.029","volume":"61","author":"V Leroy","year":"2014","unstructured":"Leroy, V., Sturm, N., Faure, P., Trocme, C., Marlu, A., Hilleret, M.N., Morel, F., and Zarski, J.P. (2014). Prospective evaluation of FibroTest\u00ae, FibroMeter\u00ae, and HepaScore\u00ae for staging liver fibrosis in chronic hepatitis B: comparison with hepatitis C. J Hepatol 61, 28\u201334.","journal-title":"J Hepatol"},{"key":"2691_CR18","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jhep.2016.02.021","volume":"64","author":"M Levrero","year":"2016","unstructured":"Levrero, M., and Zucman-Rossi, J. (2016). Mechanisms of HBV-Induced hepatocellular carcinoma. J Hepatol 64, 84\u2013101.","journal-title":"J Hepatol"},{"key":"2691_CR19","doi-asserted-by":"publisher","first-page":"45768","DOI":"10.18632\/oncotarget.17470","volume":"8","author":"Q Li","year":"2017","unstructured":"Li, Q., Lu, C., Li, W., Huang, Y., and Chen, L. (2017). Impact of age on the diagnostic performances and cut-offs of APRI and FIB-4 for significant fibrosis and cirrhosis in chronic hepatitis B. Oncotarget 8, 45768\u201345776.","journal-title":"Oncotarget"},{"key":"2691_CR20","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.jhep.2021.08.016","volume":"75","author":"MJ Nielsen","year":"2021","unstructured":"Nielsen, M.J., Leeming, D.J., Goodman, Z., Friedman, S., Frederiksen, P., Rasmussen, D.G.K., Vig, P., Seyedkazemi, S., Fischer, L., Torstenson, R., et al. (2021). Comparison of ADAPT, FIB-4 and APRI as non-invasive predictors of liver fibrosis and NASH within the CENTAUR screening population. J Hepatol 75, 1292\u20131300.","journal-title":"J Hepatol"},{"key":"2691_CR21","doi-asserted-by":"publisher","first-page":"101170","DOI":"10.1016\/j.xcrm.2023.101170","volume":"4","author":"AM Roy","year":"2023","unstructured":"Roy, A.M., Iyer, R., and Chakraborty, S. (2023). The extracellular matrix in hepatocellular carcinoma: mechanisms and therapeutic vulnerability. Cell Rep Med 4, 101170.","journal-title":"Cell Rep Med"},{"key":"2691_CR22","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41575-023-00832-w","volume":"20","author":"S Sharma","year":"2023","unstructured":"Sharma, S., Le Guillou, D., and Chen, J.Y. (2023). Cellular stress in the pathogenesis of nonalcoholic steatohepatitis and liver fibrosis. Nat Rev Gastroenterol Hepatol 20, 662\u2013678.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2691_CR23","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling, R.K., Lissen, E., Clumeck, N., Sola, R., Correa, M.C., Montaner, J., S. Sulkowski, M., Torriani, F.J., Dieterich, D.T., Thomas, D.L., et al. (2006). Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology 43, 1317\u20131325.","journal-title":"Hepatology"},{"key":"2691_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cgh.2014.04.039","volume":"13","author":"EB Tapper","year":"2015","unstructured":"Tapper, E.B., Castera, L., and Afdhal, N.H. (2015). FibroScan (vibration-controlled transient elastography): where does it stand in the united states Practice. Clin Gastroenterol Hepatol 13, 27\u201336.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2691_CR25","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/j.jhep.2015.02.039","volume":"62","author":"C Trautwein","year":"2015","unstructured":"Trautwein, C., Friedman, S.L., Schuppan, D., and Pinzani, M. (2015). Hepatic fibrosis: concept to treatment. J Hepatol 62, S15\u2013S24.","journal-title":"J Hepatol"},{"key":"2691_CR26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jhep.2017.11.013","volume":"68","author":"E Vilar-Gomez","year":"2018","unstructured":"Vilar-Gomez, E., and Chalasani, N. (2018). Non-invasive assessment of non-alcoholic fatty liver disease: clinical prediction rules and blood-based biomarkers. J Hepatol 68, 305\u2013315.","journal-title":"J Hepatol"},{"key":"2691_CR27","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/jhep.2003.50346","volume":"38","author":"C Wai","year":"2003","unstructured":"Wai, C. (2003). A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38, 518\u2013526.","journal-title":"Hepatology"},{"key":"2691_CR28","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-018-0014-9","volume":"15","author":"VWS Wong","year":"2018","unstructured":"Wong, V.W.S., Adams, L.A., de L\u00e9dinghen, V., Wong, G.L.H., and Sookoian, S. (2018). Noninvasive biomarkers in NAFLD and NASH\u2014current progress and future promise. Nat Rev Gastroenterol Hepatol 15, 461\u2013478.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2691_CR29","doi-asserted-by":"publisher","first-page":"101463","DOI":"10.1016\/j.clinre.2020.05.011","volume":"45","author":"Z Wu","year":"2021","unstructured":"Wu, Z., Ma, A.L., Xie, Q., Zhang, X.Q., Cheng, J., Zhang, D.Z., Wang, G.Q., and Zhao, H. (2021). Significant histological changes and satisfying antiviral efficacy in chronic hepatitis B virus infection patients with normal alanine aminotransferase. Antiviral therapy decision in chronic HBV patients with normal ALT. Clin Res Hepatol Gastroenterol 45, 101463.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"2691_CR30","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1111\/j.1440-1746.2010.06383.x","volume":"25","author":"K Zhou","year":"2010","unstructured":"Zhou, K., Gao, C.F., Zhao, Y.P., Liu, H.L., Zheng, R.D., Xian, J.C., Xu, H.T., Mao, Y. M., Zeng, M.D., and Lu, L.G. (2010). Simpler score of routine laboratory tests predicts liver fibrosis in patients with chronic hepatitis B. J Gastro Hepatol 25, 1569\u20131577.","journal-title":"J Gastro Hepatol"}],"container-title":["Science China Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-024-2691-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11427-024-2691-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-024-2691-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T13:07:18Z","timestamp":1737637638000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11427-024-2691-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["2691"],"URL":"https:\/\/doi.org\/10.1007\/s11427-024-2691-0","relation":{},"ISSN":["1674-7305","1869-1889"],"issn-type":[{"value":"1674-7305","type":"print"},{"value":"1869-1889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,27]]},"assertion":[{"value":"18 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of Interest. All animal experiments were approved by the Institutional Animal Care and Use Committee of Shanghai Institute of Biochemistry and Cell Biology (SIBCB-S303-2005-006).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance and ethics"}}]}}